Skip to content

Efficacy of Thai herbal formulas for the treatment of patients with prediabetes

Efficacy of Thai herbal formulas for the treatment of patients with prediabetes

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241031003
Enrollment
60
Registered
2024-10-31
Start date
2022-11-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes patients Prediabetes patients Thai herbal formulas

Interventions

Pluchea indica, Lagerstroemia speciosa, Piper sarmentosu, Zea mays , Caryota mitis (500 mg),Allium sativum, Terminalia arjuna, Terminalia bellirica, Terminalia chebula, Terminalia citrina, Garcinia h
Intervention I,Intervention I,Placebo group

Sponsors

Faculty of Traditional Thai Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were FBS < 126 mg/dL and HA1c < 5 % subjects under control for the glucose and lipid of the blood and lack of changes in the dosage of their medicines during the study, having the unified medication plan in doses and terms of the type of the medication, lack of using the insulin therapy, lack of using of tobacco and alcohol, lack of chronic or acute diseases, lack of pregnancy or lactation, lack of menopause, lack of hormone therapy, lack of following the diet for weight loss as well as lack of using the supplementary extract.

Exclusion criteria

Exclusion criteria: The exclusion criteria included sensitivity to the extract, pregnancy during the study, variation in the dosage of the medicines during the study, developing to the abovementioned diseases during the study and unwillingness to cooperation by subject.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose, Hemoglobin, Alanine Aminotransferase, Aspartate transaminase, Blood urea nitrogen and Creatinine 12 weeks Fasting blood glucose, Hemoglobin, Alanine Aminotransferase, Aspartate transaminase, Blood urea nitrogen and Creatinine Test

Secondary

MeasureTime frame
Adverse Reaction 12 weeks Adverse Reaction form

Countries

Thailand

Contacts

Public ContactThanyaluck Siriyong

Faculty of Traditional Thai Medicine, Prince of Songkla University

thanyaluck.s@psu.ac.th074282721

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026